Humoral immune response of patients infected by earlier lineages of SARS-CoV-2 neutralizes wild types of the most prevalent variants in Brazil
View ORCID ProfileAlex Pauvolid-Corrêa, Braulia Costa Caetano, Ana Beatriz Machado, Mia Araújo Ferreira, Natalia Valente, Thayssa Keren Neves, Kim Geraldo, Fernando Motta, Valdiléa Gonçalves Veloso dos Santos, Beatriz Grinsztejn, Marilda Mendonça Siqueira, View ORCID ProfilePaola Cristina Resende
doi: https://doi.org/10.1101/2022.01.24.22269379
Alex Pauvolid-Corrêa
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
2Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America
Braulia Costa Caetano
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
Ana Beatriz Machado
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
Mia Araújo Ferreira
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
Natalia Valente
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
Thayssa Keren Neves
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
Kim Geraldo
3Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, Brazil
Fernando Motta
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
Valdiléa Gonçalves Veloso dos Santos
3Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, Brazil
Beatriz Grinsztejn
3Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, Brazil
Marilda Mendonça Siqueira
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
Paola Cristina Resende
1Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted January 28, 2022.
Humoral immune response of patients infected by earlier lineages of SARS-CoV-2 neutralizes wild types of the most prevalent variants in Brazil
Alex Pauvolid-Corrêa, Braulia Costa Caetano, Ana Beatriz Machado, Mia Araújo Ferreira, Natalia Valente, Thayssa Keren Neves, Kim Geraldo, Fernando Motta, Valdiléa Gonçalves Veloso dos Santos, Beatriz Grinsztejn, Marilda Mendonça Siqueira, Paola Cristina Resende
medRxiv 2022.01.24.22269379; doi: https://doi.org/10.1101/2022.01.24.22269379
Humoral immune response of patients infected by earlier lineages of SARS-CoV-2 neutralizes wild types of the most prevalent variants in Brazil
Alex Pauvolid-Corrêa, Braulia Costa Caetano, Ana Beatriz Machado, Mia Araújo Ferreira, Natalia Valente, Thayssa Keren Neves, Kim Geraldo, Fernando Motta, Valdiléa Gonçalves Veloso dos Santos, Beatriz Grinsztejn, Marilda Mendonça Siqueira, Paola Cristina Resende
medRxiv 2022.01.24.22269379; doi: https://doi.org/10.1101/2022.01.24.22269379
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11550)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3542)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (386)
- Neurology (3327)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (523)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (436)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5975)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)